Should a Company Repeat a Study When Results Are Not as Expected?

Clinical study results should be interpreted and reported accurately, including neutral or unfavorable findings, limitations, uncertainty, adverse events, and protocol deviations, without selective reporting or misrepresentation.

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

1. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

2. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

3. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

4. Costs

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

5. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

1. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

2. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

3. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

4. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

1. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

2. Data Management

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

3. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

4. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

Conclusion

The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting.

Quick Contact